These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8519929)

  • 21. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system.
    Passirani C; Barratt G; Devissaguet JP; Labarre D
    Life Sci; 1998; 62(8):775-85. PubMed ID: 9489513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.
    Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D
    Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The polycation diethylaminoethyl dextran potentiates thermal cell killing.
    Modlinski M; Calderwood SK; Stevenson MA; Hahn GM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Nov; 46(5):587-96. PubMed ID: 6083986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan.
    Cheung AK; Parker CJ; Wilcox LA; Janatova J
    Kidney Int; 1990 Apr; 37(4):1055-9. PubMed ID: 2342244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid activation of the complement system by cuprophane depends on complement component C4.
    Lhotta K; Würzner R; Kronenberg F; Oppermann M; König P
    Kidney Int; 1998 Apr; 53(4):1044-51. PubMed ID: 9551416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
    Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
    Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
    [No Abstract]   [Full Text] [Related]  

  • 28. Adsorption of unactivated complement proteins by hemodialysis membranes.
    Cheung AK
    Am J Kidney Dis; 1989 Dec; 14(6):472-7. PubMed ID: 2596474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo complement protein adsorption on positively and negatively charged cellulose dialyser membranes.
    Mahiout A; Matata BM; Vienken J; Courtney JM
    J Mater Sci Mater Med; 1997 May; 8(5):287-96. PubMed ID: 15348751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro blood reactivity to hydroxylated and non-hydroxylated polymer surfaces.
    Sperling C; Maitz MF; Talkenberger S; Gouzy MF; Groth T; Werner C
    Biomaterials; 2007 Sep; 28(25):3617-25. PubMed ID: 17524475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.
    Lemarchand C; Gref R; Passirani C; Garcion E; Petri B; Müller R; Costantini D; Couvreur P
    Biomaterials; 2006 Jan; 27(1):108-18. PubMed ID: 16118015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
    Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
    ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modification of cellulose that facilitates the control of complement activation.
    Johnson RJ; Lelah MD; Sutliff TM; Boggs DR
    Blood Purif; 1990; 8(6):318-28. PubMed ID: 2151203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro study of C3a des Arg produced by plasma incubation with blood purification materials].
    Huang J; Cheng L; Yue Y; Wei Q
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Dec; 17(4):385-9. PubMed ID: 11211820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of diethylaminoethyl-dextran on colony formation of human tumor cells in semisolid suspension cultures.
    Hug V; Spitzer G; Drewinko B; Blumenschein GR
    Cancer Res; 1983 Jan; 43(1):210-3. PubMed ID: 6182989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation on thiol-modified gold surfaces.
    Liu L; Elwing H
    J Biomed Mater Res; 1996 Apr; 30(4):535-41. PubMed ID: 8847362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-complement activity of polysaccharide B3-PS2 purified from Herba Scutellariae Barbatae].
    Wu Y; Wei HP; Wang JB
    Yao Xue Xue Bao; 2009 Jun; 44(6):615-9. PubMed ID: 19806892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME; Kinoshita T; Nussenzweig V
    J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific antibodies enhance alternative complement pathway activation by cuprophane.
    Maillet F; Kazatchkine MD
    Nephrol Dial Transplant; 1991; 6(3):193-7. PubMed ID: 1714061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.